Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
SLC23A2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
SRCIN1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ASXL3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZNF614 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IWS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PACRGL - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PRSS33 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TTR - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PTPRK - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
THSD4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SNTB2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GATB - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZNF136 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
SLC39A11 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IL1F10 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TINAG - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TRMT10C - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on